A single infusion of VERVE-102 reduced LDL cholesterol by up to 62% in early trials. Here's what the latest cholesterol ...

As Amgen strives to become the industry’s top player in cardiometabolic risk reduction by the start of the next decade, the company took to the American Diabetes Association 2026 Scientific Sessions ...

Repatha was first approved in 2015 and has since been used by more than 8 million patients globally. 7,8 In August 2025, the U.S. Food and Drug Administration broadened the approved use of Repatha to ...

Cardiovascular disease treatment has undergone a transformation in the past 40 years, as first statins like Pfizer’s Lipitor and then “PCSK9” antibody drugs like Repatha showed that significantly ...

Repatha (evolocumab) is a prescription medication used in certain situations to lower “bad” cholesterol and reduce serious heart-related risks. Here is a quick breakdown of how it works. Your liver ...

Some common side effects of Repatha (evolocumab) include a runny nose, a sore throat, upper respiratory infections, and back pain. Serious side effects of Repatha include diabetes, angioedema (rapid ...

How Does Repatha Work for High Cholesterol? People can have high cholesterol for a number of reasons, including their diet, exercise habits, or genetic conditions. Keeping your cholesterol low, ...

MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha ® (evolocumab injection) for eligible ...

Jonathan is the deputy corporate editor at The Wall Street Journal, helping manage a team of reporters and editors who cover industries ranging from autos and airlines to retailers, food makers and ...

Dr. Danielle Weiss is the founder of the Center for Hormonal Health and Well-Being, a personalized, proactive, patient-centered medical practice with a unique focus on integrative endocrinology. She ...

VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha in High-Risk Patients, with Median 44 mg/dL LDL-C Achieved THOUSAND OAKS, Calif., March 28, 2026 /PRNewswire/ -- Amgen ...